Metabolic syndrome (MS) has been shown to increase the risk of breast cancer. Existing data suggest that the strength of metabolic syndrome-breast cancer link varies by intrinsic molecular subtype, but results from worldwide literature are controversial. Primary endpoint of the study was to assess whether MS is a predictor of specific breast cancer (BC) subtype. Secondary endpoint was to determine whether components of MS can individually increase the risk of specific breast cancer subtype.
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype / Capasso, Immacolata; Esposito, Emanuela; DE LAURENTIIS, Michelino; Maurea, Nicola; Cavalcanti, Ernesta; Botti, Gerardo; Petrillo, Antonella; Montella, Maurizio; D'Aiuto, Massimiliano; Coppola, Carmela; Crispo, Anna; Grimaldi, Maria; Frasci, Giuseppe; Fucito, Alfredo; Ciliberto, Gennaro; D'Aiuto, Giuseppe. - In: DIABETOLOGY & METABOLIC SYNDROME. - ISSN 1758-5996. - 6:1(2014), p. 105. [10.1186/1758-5996-6-105]
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
ESPOSITO, EMANUELA;DE LAURENTIIS, MICHELINO;CILIBERTO, GENNARO;
2014
Abstract
Metabolic syndrome (MS) has been shown to increase the risk of breast cancer. Existing data suggest that the strength of metabolic syndrome-breast cancer link varies by intrinsic molecular subtype, but results from worldwide literature are controversial. Primary endpoint of the study was to assess whether MS is a predictor of specific breast cancer (BC) subtype. Secondary endpoint was to determine whether components of MS can individually increase the risk of specific breast cancer subtype.| File | Dimensione | Formato | |
|---|---|---|---|
|
13098_2014_Article_365.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
270.35 kB
Formato
Adobe PDF
|
270.35 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
